New Zealand markets closed

META Jan 2026 50.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
448.550.00 (0.00%)
At close: 12:44PM EDT
Full screen
Previous close448.55
Open448.55
Bid444.45
Ask448.35
Strike50.00
Expiry date2026-01-16
Day's range448.55 - 448.55
Contract rangeN/A
Volume3
Open interest19
  • Yahoo Finance Video

    US indexes open mixed, pharmaceutical stocks climb: Morning Brief

    On today's episode of Morning Brief, hosts Brad Smith and Madison Mills analyze the market open and break down the biggest stories of the trading week. The major indexes (^DJI, ^IXIC, ^GSPC) opened mixed in Friday's session, with the Dow Jones Industrial Average leading gains early in the trading day. Nvidia's (NVDA) reign as the US's most valuable publicly traded company was brief. The semiconductor giant shed $118 billion in market capitalization, allowing Microsoft (MSFT) to reclaim the top spot. Moor Insights & Strategy founder, CEO, and chief analyst Patrick Moorhead emphasizes that Nvidia's continued dominance hinges on sustained enterprise demand for its offerings. If customers stop buying Nvidia's offerings, he warns, "then this whole gravy train comes to a screeching halt." Wells Fargo Investment Institute senior global market strategist Scott Wren notes that while the computer services and technology sectors are currently "very highly valued, very momentum driven," investors should consider trimming some of their gains in these areas and reallocating into sectors like industrials, energy, and healthcare. The pharmaceutical and biotech sectors are making major moves as Sarepta (SRPT) received expanded approval from the Food and Drug Administration for its muscular dystrophy drug, and Gilead (GILD) saw encouraging results from its twice-yearly shot to prevent HIV. Meanwhile, Oppenheimer has upgraded Nike (NKE) from Perform to Outperform and raised its price target from $110 to $120. Meta (META) also received a bullish call, as KeyBanc raised its price target from $475 to $540, citing sustained advertising momentum. Keybanc Managing Director Justin Patterson explains that Meta's ad revenue is "accelerating sequentially" despite intensifying competition, indicating that "demand for Meta's advertisements remains very high." This post was written by Melanie Riehl

  • Yahoo Finance Video

    Meta: KeyBanc raises price target on ad growth

    KeyBanc has adopted a bullish stance on Meta's (META) growth prospects. Justin Patterson, Keybanc managing director, has lifted his price target on Meta to $540 from $475, citing sustained advertising momentum. Patterson joins the Morning Brief to discuss his outlook on the tech giant. Patterson highlights that Meta's ad revenue is "accelerating sequentially" despite intensifying competition, indicating that "demand for Meta's advertisements remains very high." He notes that advertisers are willing to bid at higher rates to reach Meta's user base, emphasizing that "the returns for this AI advertising cycle are still very strong." Beyond advertising, Patterson points out Meta's broader AI benefits. He observes increased engagement across Meta's platforms due to AI investments, as well as ad-tech refinement boosting returns for advertisers. These factors, he argues, are contributing to Meta's overall gains in the market. Furthermore, with TikTok facing a potential ban, Patterson suggests that Meta's platforms could attract users needing to reallocate their social media time. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith

  • Investor's Business Daily

    Dow Jones Futures: Market Rally Pauses As Nvidia Skids; Fed Inflation Gauge Ahead

    The stock market paused late in the week as Nvidia led AI chips lower. Micron earnings and the Fed's inflation gauge loom.